Table of Contents
Chapter 1 Overview of Dihydroartemisinin
    1.1 Definition of Dihydroartemisinin in This Report
    1.2 Commercial Types of Dihydroartemisinin
        1.2.1 PharmaceuticalGrade
        1.2.2 IndustrialGrade
    1.3 Downstream Application of Dihydroartemisinin
        1.3.1 MalariaTreatment
        1.3.2 ScientificResearch
        1.3.3 Others
    1.4 Development History of Dihydroartemisinin
    1.5 Market Status and Trend of Dihydroartemisinin 2016-2026
        1.5.1 Global Dihydroartemisinin Market Status and Trend 2016-2026
        1.5.2 Regional Dihydroartemisinin Market Status and Trend 2016-2026
Chapter 2 Global Market Status and Forecast by Regions
    2.1 Market Development of Dihydroartemisinin 2016-2021
    2.2 Sales Market of Dihydroartemisinin by Regions
        2.2.1 Sales Volume of Dihydroartemisinin by Regions
        2.2.2 Sales Value of Dihydroartemisinin by Regions
    2.3 Production Market of Dihydroartemisinin by Regions
    2.4 Global Market Forecast of Dihydroartemisinin 2022-2026
        2.4.1 Global Market Forecast of Dihydroartemisinin 2022-2026
        2.4.2 Market Forecast of Dihydroartemisinin by Regions 2022-2026
Chapter 3 Global Market Status and Forecast by Types
    3.1 Sales Volume of Dihydroartemisinin by Types
    3.2 Sales Value of Dihydroartemisinin by Types
    3.3 Market Forecast of Dihydroartemisinin by Types
Chapter 4 Global Market Status and Forecast by Downstream Industry
    4.1 Global Sales Volume of Dihydroartemisinin by Downstream Industry
    4.2 Global Market Forecast of Dihydroartemisinin by Downstream Industry
Chapter 5 North America Market Status by Countries, Type, Manufacturers and Downstream Industry
    5.1 North America Dihydroartemisinin Market Status by Countries
        5.1.1 North America Dihydroartemisinin Sales by Countries (2016-2021)
        5.1.2 North America Dihydroartemisinin Revenue by Countries (2016-2021)
        5.1.3 United States Dihydroartemisinin Market Status (2016-2021)
        5.1.4 Canada Dihydroartemisinin Market Status (2016-2021)
        5.1.5 Mexico Dihydroartemisinin Market Status (2016-2021)
    5.2 North America Dihydroartemisinin Market Status by Manufacturers
    5.3 North America Dihydroartemisinin Market Status by Type (2016-2021)
        5.3.1 North America Dihydroartemisinin Sales by Type (2016-2021)
        5.3.2 North America Dihydroartemisinin Revenue by Type (2016-2021)
    5.4 North America Dihydroartemisinin Market Status by Downstream Industry (2016-2021)
Chapter 6 Europe Market Status by Countries, Type, Manufacturers and Downstream Industry
    6.1 Europe Dihydroartemisinin Market Status by Countries
        6.1.1 Europe Dihydroartemisinin Sales by Countries (2016-2021)
        6.1.2 Europe Dihydroartemisinin Revenue by Countries (2016-2021)
        6.1.3 Germany Dihydroartemisinin Market Status (2016-2021)
        6.1.4 UK Dihydroartemisinin Market Status (2016-2021)
        6.1.5 France Dihydroartemisinin Market Status (2016-2021)
        6.1.6 Italy Dihydroartemisinin Market Status (2016-2021)
        6.1.7 Russia Dihydroartemisinin Market Status (2016-2021)
        6.1.8 Spain Dihydroartemisinin Market Status (2016-2021)
        6.1.9 Benelux Dihydroartemisinin Market Status (2016-2021)
    6.2 Europe Dihydroartemisinin Market Status by Manufacturers
    6.3 Europe Dihydroartemisinin Market Status by Type (2016-2021)
        6.3.1 Europe Dihydroartemisinin Sales by Type (2016-2021)
        6.3.2 Europe Dihydroartemisinin Revenue by Type (2016-2021)
    6.4 Europe Dihydroartemisinin Market Status by Downstream Industry (2016-2021)
Chapter 7 Asia Pacific Market Status by Countries, Type, Manufacturers and Downstream Industry
    7.1 Asia Pacific Dihydroartemisinin Market Status by Countries
        7.1.1 Asia Pacific Dihydroartemisinin Sales by Countries (2016-2021)
        7.1.2 Asia Pacific Dihydroartemisinin Revenue by Countries (2016-2021)
        7.1.3 China Dihydroartemisinin Market Status (2016-2021)
        7.1.4 Japan Dihydroartemisinin Market Status (2016-2021)
        7.1.5 India Dihydroartemisinin Market Status (2016-2021)
        7.1.6 Southeast Asia Dihydroartemisinin Market Status (2016-2021)
        7.1.7 Australia Dihydroartemisinin Market Status (2016-2021)
    7.2 Asia Pacific Dihydroartemisinin Market Status by Manufacturers
    7.3 Asia Pacific Dihydroartemisinin Market Status by Type (2016-2021)
        7.3.1 Asia Pacific Dihydroartemisinin Sales by Type (2016-2021)
        7.3.2 Asia Pacific Dihydroartemisinin Revenue by Type (2016-2021)
    7.4 Asia Pacific Dihydroartemisinin Market Status by Downstream Industry (2016-2021)
Chapter 8 Latin America Market Status by Countries, Type, Manufacturers and Downstream Industry
    8.1 Latin America Dihydroartemisinin Market Status by Countries
        8.1.1 Latin America Dihydroartemisinin Sales by Countries (2016-2021)
        8.1.2 Latin America Dihydroartemisinin Revenue by Countries (2016-2021)
        8.1.3 Brazil Dihydroartemisinin Market Status (2016-2021)
        8.1.4 Argentina Dihydroartemisinin Market Status (2016-2021)
        8.1.5 Colombia Dihydroartemisinin Market Status (2016-2021)
    8.2 Latin America Dihydroartemisinin Market Status by Manufacturers
    8.3 Latin America Dihydroartemisinin Market Status by Type (2016-2021)
        8.3.1 Latin America Dihydroartemisinin Sales by Type (2016-2021)
        8.3.2 Latin America Dihydroartemisinin Revenue by Type (2016-2021)
    8.4 Latin America Dihydroartemisinin Market Status by Downstream Industry (2016-2021)
Chapter 9 Middle East and Africa Market Status by Countries, Type, Manufacturers and Downstream Industry
    9.1 Middle East and Africa Dihydroartemisinin Market Status by Countries
        9.1.1 Middle East and Africa Dihydroartemisinin Sales by Countries (2016-2021)
        9.1.2 Middle East and Africa Dihydroartemisinin Revenue by Countries (2016-2021)
        9.1.3 Middle East Dihydroartemisinin Market Status (2016-2021)
        9.1.4 Africa Dihydroartemisinin Market Status (2016-2021)
    9.2 Middle East and Africa Dihydroartemisinin Market Status by Manufacturers
    9.3 Middle East and Africa Dihydroartemisinin Market Status by Type (2016-2021)
        9.3.1 Middle East and Africa Dihydroartemisinin Sales by Type (2016-2021)
        9.3.2 Middle East and Africa Dihydroartemisinin Revenue by Type (2016-2021)
    9.4 Middle East and Africa Dihydroartemisinin Market Status by Downstream Industry (2016-2021)
Chapter 10 Market Driving Factor Analysis of Dihydroartemisinin
    10.1 Global Economy Situation and Trend Overview
    10.2 Dihydroartemisinin Downstream Industry Situation and Trend Overview
Chapter 11 Dihydroartemisinin Market Competition Status by Major Manufacturers
    11.1 Production Volume of Dihydroartemisinin by Major Manufacturers
    11.2 Production Value of Dihydroartemisinin by Major Manufacturers
    11.3 Basic Information of Dihydroartemisinin by Major Manufacturers
        11.3.1 Headquarters Location and Established Time of Dihydroartemisinin Major Manufacturer
        11.3.2 Employees and Revenue Level of Dihydroartemisinin Major Manufacturer
    11.4 Market Competition News and Trend
        11.4.1 Merger, Consolidation or Acquisition News
        11.4.2 Investment or Disinvestment News
        11.4.3 New Product Development and Launch
Chapter 12 Dihydroartemisinin Major Manufacturers Introduction and Market Data
    12.1 Sanofi
        12.1.1 Company profile
        12.1.2 Representative Dihydroartemisinin Product
        12.1.3 Dihydroartemisinin Sales, Revenue, Price and Gross Margin of Sanofi
    12.2 KPCPharmaceuticals
        12.2.1 Company profile
        12.2.2 Representative Dihydroartemisinin Product
        12.2.3 Dihydroartemisinin Sales, Revenue, Price and Gross Margin of KPCPharmaceuticals
    12.3 GuangxiXiancaotangPharmaceutical
        12.3.1 Company profile
        12.3.2 Representative Dihydroartemisinin Product
        12.3.3 Dihydroartemisinin Sales, Revenue, Price and Gross Margin of GuangxiXiancaotangPharmaceutical
    12.4 GuilinPharmaceutical
        12.4.1 Company profile
        12.4.2 Representative Dihydroartemisinin Product
        12.4.3 Dihydroartemisinin Sales, Revenue, Price and Gross Margin of GuilinPharmaceutical
    12.5 KeruiNanhaiPharmaceutical
        12.5.1 Company profile
        12.5.2 Representative Dihydroartemisinin Product
        12.5.3 Dihydroartemisinin Sales, Revenue, Price and Gross Margin of KeruiNanhaiPharmaceutical
    12.6 ShanghaiNaturalBio-engineeringCo
        12.6.1 Company profile
        12.6.2 Representative Dihydroartemisinin Product
        12.6.3 Dihydroartemisinin Sales, Revenue, Price and Gross Margin of ShanghaiNaturalBio-engineeringCo
    12.7 NovanatBioresource
        12.7.1 Company profile
        12.7.2 Representative Dihydroartemisinin Product
        12.7.3 Dihydroartemisinin Sales, Revenue, Price and Gross Margin of NovanatBioresource
    12.8 BotanicalExtractsEPZLtd
        12.8.1 Company profile
        12.8.2 Representative Dihydroartemisinin Product
        12.8.3 Dihydroartemisinin Sales, Revenue, Price and Gross Margin of BotanicalExtractsEPZLtd
Chapter 13 Upstream and Downstream Market Analysis of Dihydroartemisinin
    13.1 Industry Chain of Dihydroartemisinin
    13.2 Upstream Market and Representative Companies Analysis
    13.3 Downstream Market and Representative Companies Analysis
Chapter 14 Cost and Gross Margin Analysis of Dihydroartemisinin
    14.1 Cost Structure Analysis of Dihydroartemisinin
    14.2 Raw Materials Cost Analysis of Dihydroartemisinin
    14.3 Labor Cost Analysis of Dihydroartemisinin
    14.4 Manufacturing Expenses Analysis of Dihydroartemisinin
Chapter 15 Report Conclusion
Chapter 16 Research Methodology and Reference
    16.1 Methodology/Research Approach
        16.1.1 Research Programs/Design
        16.1.2 Market Size Estimation
        16.1.3 Market Breakdown and Data Triangulation
    16.2 Data Source
        16.2.1 Secondary Sources
        16.2.2 Primary Sources
    16.3 Reference